Company / Depreciation & Amortization
DaVita Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$708.3M
FY2025
5-year range
$600.9M / $716.4M
FY2021-FY2025
Trend
-1.1%
vs FY2024
Sector context
#19 of 142
Health Care
What the data says
DaVita's depreciation & amortization of $708M is higher than 87% of companies in the Health Care sector (FY2025). Depreciation & Amortization has fluctuated over the past 10 years, ranging from $495M in FY2018 to $716M in FY2024.
Based on SEC 10-K filings.
$708M in FY2025 with a 5-year CAGR of +4.3%. Top quartile in the Health Care sector.
Increased from $668M to $708M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +4.7%
- 5-Year CAGR
- +4.3%
- 10-Year CAGR
- -
Sector benchmark
+103.9% above sector average
Key checks
Key Insights
- 5-year CAGR of +4.3%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 1.1% year-over-year.
- Ranks #19 out of 142 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $708.3M | -1.1% |
| FY2024 | $716.4M | +7.3% |
| FY2023 | $667.8M | +8.3% |
| FY2022 | $616.6M | +2.6% |
| FY2021 | $600.9M | +4.5% |
| FY2020 | $574.8M | +5.6% |
| FY2019 | $544.1M | +9.9% |
| FY2018 | $494.9M | -9.0% |
| FY2017 | $544.1M | +9.9% |
| FY2016 | $494.9M | +11.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026